Search

everythinglearnresearchcommunity

for

Search:↓

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Adrenal disorders can cause lasting brain and behavior issues in children.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Menopause affects hair and skin; more research needed for treatment.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Dermal papilla cells are key for hair growth and could help us understand and treat hair loss.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.